Labs (Quiz 2) Flashcards

1
Q

Examples of universal and selected screenings a different ages throughout childhood

A

Newborn:

  • ID genetic, metabolic, developmental issues via blood on filter paper (HRSA recommends 30 dos, all states do at least 21, some >30)
    • newest NBS is for critical congenital heart disease (pulse oximetry and pulse)
  • Hearing screening in 43 states + PR and DC

IDA: 12 mo Hgb screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Rationale for newborn screening

A

Testing, Tracking, Treating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Role of APRN in newborn screening

A
  • Educate parents during pregnancy
  • f/u abnl results asap - locate baby
  • if +, arrange f/u w/appropriate specialists (use ACT sheets)
  • Continue f/u and support in PC
    • complete medical hx
    • Signs illness (GI, cardiac, neuro)
    • Dvptl/neuro f/u
  • Continue care w/specialists
  • Reassure; stress importance of adherence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Available tools for newborn screening

A
  • National Newborn Screening and Genetics Resource Center: comprehensive source of info
  • American College of Medical Genetics
    • Includes “ACT” sheets (ACTion) - info for providers what to do if screen +, specialists
      • immediate steps for + newborn screening: family contact, specialist, evaluation, confirmatory testing, tx, education, algorithm including BW results
  • March of Dimes: consumer friendly reading, video about screening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of hyperbilirubinemia

A

Bilirubin is product of RBC breakdown.

  • unconjugated (indirect) bilirubin: 2/2 abnormality of bilirubin metabolism / excretion (physiologic jaundice of newborn) (our focus)
  • conjugated (direct) bilirubin: sugars are attached to bilirubin, 2/2 biliary obstruction/cholestasis (hepatitis, pancreatitis, biliary atresia, sepsis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are breast milk jaundice and breastfeeding failure jaundice?

How are they managed?

A
  • Breast milk jaundice:
    • = physiologic jaundice > 1 week of age
    • Presents 3-5 days of life, peaks 2 weeks of age, declines 3-12 weeks
    • Usually total bili >5mg/dL, but generally mild and does not require intervention >> monitor for increases
  • Breastfeeding failure jaundice
    • sub-optimal breastfeeding >> inadequate intake >> decreased stools
    • First 7 days of life
    • Results in excessive weight and fluid loss and decreased bili elimination
    • Prevention: breastfeed 8-12x/day

**if babies have jaundice that require intervention – phototherapy, bili blanket, blood exchange transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of unconjugated hyperbilirubinemia

A
  • Hemolysis: blood group incompatabilit, infection, hemoglobinopathies, RBC enzyme defects, RBC membrane DOs…
  • No hemolysis: breast milk jaundice, infant of mother w/DM, internal hemorrhage, physiologic jaundice, polycythemia, hypothyroidism, Gilbert syndrome, pyloric stenosis…
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical sx of hyperbilirubinemia

A
  • Simple jaundice: bili >5-6 mg/dL, skin yellow (60% of newborns in 1st wk, cranial-caudal progression, best seen in periphery of conjunctivae and in oral mm (under tongue, hard palate))
    • may have some sleepiness, feeding difficulty
  • Acute bilirubin encephalopathy: as above+ lethargy, hypotonia, poor suck
    • may have irritability, hypertonia, high pitched cry, fever, seizures
  • Kernicterus: above + athetoid cerebral palsy, hearing loss, gase palsies, dental enamel hypoplasia
    • ●TB >20 and ≤25 mg/dL – Risk of kernicterus usually only in conjunction with a co-morbid condition
    • ●TB >25 and ≤30 mg/dL – 6 percent
    • ●TB >30 and ≤35 mg/dL – 14 to 25 percent
    • ●TB >35 mg/dL – Almost all infants will have signs of kernicterus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bilirubin: nl range, when increased risk for kernicterus, nl peak

A
  • Bilirubin
    • Elevated > 2.5-3mg/dL
    • Increased risk for kernicterus > 20mg/dL
    • Bilirubin peaks at age 3-5days (5-7days if premature; also later in Asian infants)
    • Mean peak total serum bilirubin is 6mg/dL (higher in Asian infants)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Transcutaneous vs serum bili

A
  • Transcutaneous:
    • Advantages: used as screening tool in newborns; no blood lab needed
    • Disadvantages: TcB does not distinguish between conjugated + unconjugated; levels may be affected by skin pigmentation
    • Follow up with serum TB if TcB >95th percentile OR TcB > 13mg/dL
  • Serum:
    • Total and direct bilirubin levels
    • Used to confirm TcB values if questioning validity of TcB
    • Used if infant undergoing phototherapy
    • Consider cholestasis if conjugate bilirubin >1mg/dL + TB <5mg/dL

* Interpret all levels according to baby’s age in hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Other labs that may be useful in assessing hyperbilirubinemia

A
  • CBC (for H/H)
  • Low hemoglobin may indicate hemolysis
  • Peripheral blood smear (for RBC morphology)
  • Hemolysis can be confirmed by presence of fragmented cells in smear
  • Reticulocyte count
  • Rising reticulocyte count is consistent with RBC destruction
  • Coomb’s test
  • Comparison of mother and infant’s blood type to see if there’s a possibility of isoimmune hemolytic disease (mother’s antibodies destroy newborn’s RBC)
  • G6PD measurement
  • If either parent is Mediterranean, Nigerian or East Asian OR
  • If TB > 18/mg/dL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors for hyperbilirubinemia

major, minor, reduced

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What tool is available to determine phototherapy needs, how is it used?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When to send to the hospital for hyperbilirubinemia?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Components of a CBC

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

RBC indices

(not #s)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Macro / micro / normo cytic anemias

A
  • Microcytic anemia: MCV low
    • e.g. IDA - universal screening at 12mo but still high prevalence, 9% ado females have IDA (no universal screening). Risks: premature, BF w/o iron supp after 6mo, hispanic, lead exposure, heavy menses, cow’s milk before 12mo
  • Macrocytic anemia: MCV high
  • Normocytic anemia: MCV nl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

von Willebrand Disease (vWD): what is it?

A
  • most common inherited bleeding DO (1% of population)
  • autosomal inheritance (M-F equally affected)
  • VWF carries clotting protein factor VIII
  • Many types: Type 1 is most common and mildest
19
Q

VWD: important history and exam findings?

A
  • History:
    • Easy bruising
    • Bruising in unusual locations
    • Abnormal menstrual bleeding
    • Bleeding in mucous membranes (gums, nose, GI tract)
    • Prolonged nose bleeds (>10 mins)
    • Excessive or prolonged bleeding at dentist, post-op
    • If severe vWD, presentation is early (i.e., circumcision)
  • On exam:
    • Large bruising on trunk and anterior chest
    • Otherwise well-appearing
20
Q

Initial Lab diagnostics for VWD

A
  • CBC w/diff: nl, no abnormality in PLTs
  • PT: nl
  • aPTT: nl

Then you try VWD screening

  • plasma von Willebrand factor antigen: Low
  • Plasma VWF activity (rostocetin cofactor activity, VWF collagen binding): both low
  • Factor VIII activity: low or nl
21
Q

MGMT / referral for VWD

A

If none of the screenings for VWD are abnormal, refer for selected specialized VWD studies / hematological evaluation

Tx: DDAVP often effective

22
Q

Description and function of platelets

A

a.k.a. thrombocytes

Role of platelets is to prevent bleeding

23
Q

Disorder associated with decreased platelets

characteristics

A

Idiopathic thrombocytopenic purpura

  • Most common acquired bleeding disorder
  • Immune-mediated destruction of platelets (plt < 100K) in otherwise nl CBC
  • Slight predominance boys > girls
  • Peak incidence between 2 and 5 yo, but can present at any age
  • In about 60% of pediatric cases, there is a history of prior infection within the past month
  • In 80% of pediatric cases, ITP resolves without treatment, usually within 6 months
24
Q

Differentials

non-blanching rash

A
  • Vascular dysfunction (vasculitis): Henoch Schonlein Purpura, Kawasaki disease
  • Blood clotting disorder: hyper/hypo coagulable states: hemophilia
  • Idiopathic thrombocytopenic purpura
  • Long term steroid tx
  • Hemangioma
  • meningococcemia
  • Rocky mountain spotted fever
  • DIC
  • Leukemia
25
Q

WBCs: types of cells and roles of each

A
  • Neutrophils ( bands) 53%: infection, bacteria
  • Lymphocytes 36%: Abs, immunity
  • Monocytes 9%: phagocytosis
  • Eosinophils 2%: parasites, allergies, neoplasms
  • Basophils: immune function, release heparin and histamine
26
Q

What is indicated by a high or low WBC?

A
  • high wbcs: infection, maybe HSP (if following infxn)
  • Low wbcs: bone marrow failure or infiltration (leukemia, lymphoma, hemophagocytic lymphohistiocytosis)
27
Q

Risk factors for lead expsure

A
  • Paint in homes built before 1978.
  • Water pumped through leaded pipes.
  • Imported items including clay pots.
  • Certain consumer products
  • Candies, make -up jewelry.
  • Certain imported home remedies.
  • <6yo, living below poverty level
  • some racial and ethnic groups
28
Q

Effects of lead exposure

A
  • CNS
    • Development
    • lower IQ
    • ADHD
    • Seizures
    • Headaches
    • Increased ICP
  • GI-
    • constipation
    • vomiting
    • abdominal pain
    • anorexia
  • HEME- anemia
29
Q

Clinical Presentation of lead exposure

A
  • Low concentrations
    • Vomiting
    • Cognitive impairment
    • Language delay
    • Hearing loss
    • Behavior problems
  • Higher concentrations
    • Colicky abdominal pain
    • Anemia
    • Intellectual disability
    • Seizures
    • Renal insufficiency
    • Encephalopathy
30
Q

Recommended screening for lead exposure

A
  • capillary sample: Routine 12 and 24 mo
  • Continue after 2yo if RFs!
  • Venous sample: > 5 mcg/dL is positive
31
Q

Current values and classifications regarding lead exposure

A
32
Q

MGMT/Tx of lead exposure

A
  • Mild: _<_44 mcg/dL
    • <5mcg - check at least yearly, maybe more
    • 5-14 mg - recheck in 1mo, 3 mo, education
    • 15-19 mcg - 1 mo, 2mo, educate
    • 20-44 mcg - report to public health, recheck, educate, no chelation
  • Moderate: 45-69
    • admission, chelation w/toxicologist (po or IV), check BLL until <45, Q3mo check
  • Severe: >70
    • emergency admission, signs of encephalopathy?, check until <45, Q2-3mo check
33
Q

Components of a CMP

A
  • Glucose
  • BUN
  • Creatinine
  • Sodium
  • Potassium
  • Chloride
  • Carbon Dioxide
  • Calcium
  • Protein
  • Albumin
  • Bilirubin, total
  • Alk phosph
  • AST
  • ALT
34
Q

Examples of pedi conditions for which you would order a cmp and what you might find

LIVER

A
  • To evaluate LIVER FUNCTION e.g., if jaundice, HSM, obesity, suspect hepatitis, OD, malnutrition, Wilson Dz, abd pain w/alarm findings, etc.
    • cholestasis / obstructive bile duct injury: increased alk phos, conj bili, (GGT)
    • viral or toxic insult to liver cells: increased ALT, AST, (LDH)
    • NAFLD: increased ALT, AST, Alk phos, (GGT)
    • Malnutrition: labs generally not indicated unless FTT - decreased albumin, total protein, (prealbumin)
    • Wilson’s: increased total bili, ast > alt, alk phos may be low, may see damage to liver fx (decreased albumin, increased PT)
35
Q

Examples of pedi conditions for which you would order a cmp and what you might find

kidney function

A
  • Usually BMP (CHEM 7) is sufficient in evaluating renal function
  • conditions
    • AKI (prerenal, intrinsic, postrenal): order cmp/bmp if s/s e.g., edema, decreased/no UO, gross and microscopic hematuria, HTN
    • CKD: often 2/2 congenital abnormalities (routine UA no longer recommended). May notice subtle signs, polyuria, poor growth, 2 positive albumin on UA
36
Q

Examples of pedi conditions for which you would order a cmp and what you might find

A
  • Suspect impaired liver or kidney function
  • Abdominal/GI alarm symptoms
  • Medication monitoring
37
Q

How to interpret CMP changes: chart

A
38
Q

Difference between ESR and CRP

A
  • Both commonly used to measure inflammation - nonspecific, but simple and cost effective to distinguish from non-inflammatory
  • CRP: acute phase protein, produced by hepatocytes, triggered by cytokine production. Begins to rise 4-6h after inflammatory stimulus, peaks 48-72h, rapid decline w/tx. May indicate minor inflammation to CTD
  • ESR: rate at which RBCs sediment in 1hr. indirect measure of acute phase reactants. Dependent on ability of RBCs to aggregate. Can be affected by RBC size, shape and number, technical factors (unrelated to inflammation), less valuable in assessing acute changes - can be 2/2 events from weeks to months prior.
39
Q

Indications for ordering ESR or CRP

A
  • Non-specific. Useful to distinguish between inflammatory and non-inflammatory DOs
40
Q

What are thyroid indices?

A

commonly TSH, Free T4, T3

41
Q

PE / lab findings suggestive of hyperthyroidism

A
  • Enlarged thyroid on exam
  • hyperactivity
  • unintentional weight loss
  • unexplained tachycardia
  • heat intolerance
  • declining school performance
  • order labs if >1 sx

Expected Labs: Low TSH, High free T4

42
Q

PE / lab findings suggestive of hypothyroidism

A
  • enlarged thyroid on exam
  • new onset fatigue
  • cold intolerance
  • acquired growth failure
  • constipation, dry skin

Expected Labs: high TSH, low free T4

43
Q

Is thyroid testing useful in obesity?

A
  • no - low yield unless concomitant slow linear growth
    • even severe hypothyroid causes minimal wt gain (5-10 lbs) which is mainly water not fat
  • Other low yield conditions for ordering thyroid studies: mild short stature (3-10%ile) w/nl growth rate, infants w/FTT (poor wt gain), FH thyroid dz w/no sx in child, menstrual abnl, hyperactivity alone